Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
107.79
(
2.56%
)
Bitcoin
68,062.05
(
-1.20%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 100974

Thursday, 08/05/2010 10:42:52 PM

Thursday, August 05, 2010 10:42:52 PM

Post# of 257269

IDIX—[CEO] J.P. [Sommadossi], if I understood him correctly, anticipates that IDIX's first pivotal trial will include 184 + 320 + peg/riba against telaprevir + peg/riba.

It’s notable that JP said Telaprevir, specifically, rather than “a first-generation PI.” JP presumably read MRK’s PR in #msg-52949888 before speaking at the BMO conference today :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today